Intracellular delivery of bacterial effectors for cancer therapy using biodegradable lipid nanoparticles

Bacterial effector proteins are virulence factors that are secreted and mediate orthogonal post-translational modifications of proteins that are not found naturally in mammalian systems. They hold great promise for developing biotherapeutics by regulating malignant cell signaling in a specific and targeted manner. However, delivering Bacterial effectors into disease cells poses a significant challenge to their therapeutic potential. In this study, we report on the design of a combinatorial library of bioreducible lipid nanoparticles containing disulfide bonds for highly efficient Bacterial effector delivery and potential Cancer therapy. A leading lipid, PPPDA-O16B, identified from the library, can encapsulate and deliver DNA plasmids into cells. The gene cargo is released in response to the reductive cellular environment that is upregulated in Cancer cells, leading to enhanced gene delivery and protein expression efficiency. Furthermore, we demonstrate that PPPDA-O16B can deliver the Bacterial effector protein, DUF5, to degrade mutant Ras and inactivate downstream MAPK signaling cascades to suppress Cancer cell growth in vitro and in tumor-bearing mouse xenografts. This strategy of delivering Bacterial effectors using biodegradable lipid nanoparticles can be expanded for Cancer cell signaling regulation and antitumor studies.